HEAD JONATHAN FREDERICK 4
4 · OncBioMune Pharmaceuticals, Inc · Filed May 11, 2018
Insider Transaction Report
Form 4
HEAD JONATHAN FREDERICK
DirectorChief Executive Officer
Transactions
- Award
Option (right to buy)
2018-05-09+3,000,000→ 5,000,000 totalExercise: $0.01From: 2019-05-09Exp: 2028-05-09→ Common Stock (3,000,000 underlying)
Footnotes (1)
- [F1]Options issued as compensation approved by the Issuer's Board of Directors.